Prognostic significance of palliative gastrectomy in incurable advanced gastric cancer: a retrospective cohort study and meta-analysis

被引:10
作者
Zheng, C. [1 ]
Gao, Z-M [1 ]
Huang, H-B [1 ]
Li, K. [1 ]
Liu, X-F [1 ]
机构
[1] China Med Univ, Dept Surg Oncol & Gen Surg, Affiliated Hosp, Shenyang, Peoples R China
关键词
Gastric cancer; Incurable; Palliative gastrectomy; Metastasis; NON-CURATIVE GASTRECTOMY; PLUS CHEMOTHERAPY; SURVIVAL BENEFIT; RESECTION; SURGERY; MORTALITY; IMPACT; RATES; AGE;
D O I
10.26355/eurrev_202103_25262
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: There is controversy regarding the role of palliative gastrectomy in patients with incurable advanced gastric cancer requiring surgical intervention. The present retrospective cohort study and meta-analysis aimed to determine whether palliative gastrectomy plus chemotherapy can prolong the survival of patients with incurable advanced gastric cancer requiring surgical intervention. PATIENTS AND METHODS: The data from 153 patients diagnosed with incurable advanced gastric cancer requiring surgical intervention at our institute between January 2000 and December 2012 were retrospectively reviewed. We analyzed the value of palliative gastrectomy and identified the potential prognostic factors. We also conducted a meta-analysis of 10 studies to validate our results. RESULTS: Multivariate analysis indicated that palliative gastrectomy was a favorable independent prognostic factor for prolonged overall survival in incurable advanced gastric cancer patients requiring surgical intervention (p=0.029). The median survival of patients who underwent palliative gastrectomy plus chemotherapy was significantly longer than that of those who underwent non-resection surgery plus chemotherapy (12 months vs. 9 months, p=0.020). The patients in the non-resection surgery plus chemotherapy group exhibited significantly shorter overall survival than those in the D1+ lymphadenectomy group, D2 lymphadenectomy group, or distal gastrectomy group (p=0.021, p= 0.007, and p=0.006, respectively). Our meta-analysis revealed that gastrectomy plus chemotherapy improved long-term survival in incurable advanced gastric cancer patients (hazard ratio (HR): 0.48; 95% confidence interval (CI): 0.35-0.67; p<0.001). CONCLUSIONS: Palliative gastrectomy plus chemotherapy may improve overall patient survival compared with non-resection operations plus chemotherapy in incurable advanced gastric cancer patients requiring surgical intervention.
引用
收藏
页码:2299 / 2312
页数:14
相关论文
共 50 条
  • [41] Development of a staging system and survival prediction model for advanced gastric cancer patients without adjuvant treatment after curative gastrectomy: A retrospective multicenter cohort study
    Park, Ki Bum
    Jun, Kyong-Hwa
    Song, Kyo Young
    Chin, Hyungmin
    Lee, Han Hong
    INTERNATIONAL JOURNAL OF SURGERY, 2022, 101
  • [42] Prognostic and clinical significance of VEGFR-3 in gastric cancer: A meta-analysis
    Ge, Hua
    Yan, Yan
    Guo, Lingfei
    He, Xueyan
    Yang, Xianzhi
    CLINICA CHIMICA ACTA, 2017, 474 : 114 - 119
  • [43] Prognostic and clinical significance of claudin-4 in gastric cancer: a meta-analysis
    Liu, Jin-xin
    Wei, Zhao-yi
    Chen, Jian-she
    Lu, Hai-chao
    Hao, Liang
    Li, Wen-jing
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
  • [44] Prognostic Significance of Neutrophil Lymphocyte Ratio in Patients with Gastric Cancer: A Meta-Analysis
    Zhang, Xi
    Zhang, Wei
    Feng, Li-jin
    PLOS ONE, 2014, 9 (11):
  • [45] Prognostic Significance of ADAM17 for Gastric Cancer Survival: A Meta-Analysis
    Ni, Peng
    Yu, Mingyang
    Zhang, Rongguang
    He, Mengya
    Wang, Haiyan
    Chen, Shuaiyin
    Duan, Guangcai
    MEDICINA-LITHUANIA, 2020, 56 (07): : 1 - 11
  • [46] Completely laparoscopic versus open gastrectomy for early and advanced gastric cancer: a matched cohort study
    Moisan, Fabrizio
    Norero, Enrique
    Slako, Milenko
    Varas, Julian
    Palominos, Gonzalo
    Crovari, Fernando
    Ibanez, Luis
    Perez, Gustavo
    Pimentel, Fernando
    Guzman, Sergio
    Jarufe, Nicolas
    Boza, Camilo
    Escalona, Alex
    Funke, Ricardo
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2012, 26 (03): : 661 - 672
  • [47] Validity and safety of laparoscopic gastrectomy with D1+lymphadenectomy for very elderly advanced gastric cancer patients; retrospective cohort study
    Fujimoto, Daisuke
    Taniguchi, Keizo
    Takashima, Junpei
    Miura, Fumihiko
    Kobayashi, Hirotoshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (11) : 1282 - 1288
  • [48] Thirty-Day Readmission After Radical Gastrectomy for Gastric Cancer: A Meta-analysis
    Zhang Dan
    Deng YiNan
    Yang ZengXi
    Wang XiChen
    Pan JieBin
    Yin LanNing
    JOURNAL OF SURGICAL RESEARCH, 2019, 243 : 180 - 188
  • [49] Laparoscopy-Assisted Versus Open Total Gastrectomy for Gastric Cancer: A Meta-analysis
    Shen, Hongliang
    Shan, Chengxiang
    Liu, Sheng
    Qiu, Ming
    JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES, 2013, 23 (10): : 832 - 840
  • [50] Bursectomy for advanced gastric cancer: an update meta-analysis
    Nie, Run-Cong
    Yuan, Shu-Qiang
    Chen, Shi
    Yan, Shu-Mei
    Chen, Yong-Ming
    Chen, Xiao-Jiang
    Chen, Guo-Ming
    Zhou, Zhi-Wei
    Chen, Ying-Bo
    Li, Yuan-Fang
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16